Brito PK, Cañete VR, del Puerto HM, González LME

Language: Spanish
References: 8
Page: 719-724
PDF size: 63.32 Kb.

ABSTRACT

Clinical trials are controlled and planned experiments involving human volunteers, used to evaluate the efficacy and safeness of surgical, medical and sanitary interventions, and also to determine the pharmacologic, pharmacokinetics or pharmacodynamic effects of new therapeutic products, including their adverse reactions study. Considered the paradigm of the epidemiologic research, because they are the designs that are more similar to an experiment due to the control of the conditions under study, and because they could establish cause-effect relations, the clinical trials favor decision-making in public health and, beginning from the moment of the implementation of their results, they contribute to the increase of the life quality of human beings wherever they live. The priority of health care decision-makers should be seeing for their correct design, evaluation and followingup by the scientific councils and research ethic committees, and also for the adequate interpretation of the results and their publication.

REFERENCES

1. Silva Ayçaguer LC. Deficiencias en la formulación de problemas de investigación en ciencias de la salud. Metas de Enferm [Internet]. 2004 [citado 12 May 2015];7(2):51-5. Disponible en: http://promociondeeventos.sld.cu/psicosalud/files/2008/05/deficiencias_en_la_for mulacion.pdf

2. Manríquez J, Valdivia G, Rada G, Letelier LM. Análisis crítico de ensayos clínicos randomizados publicados en revistas biomédicas chilenas. Rev Méd Chile [Internet]. 2005 [citado 12 May 2015];133:439-46. Disponible en: http://www.scielo.cl/scielo.php?pid=S0034- 98872005000400007&script=sci_arttext

3. Clyburne-Sherin AV, Thurairajah P, Kapadia MZ, et al . Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews. Trials. 2015;16(1):417. Citado en PubMed; PMID:23152285.

4. Turner L, Shamseer L, Altman DG, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev. 2012 Nov 14;11: MR000030. Citado en PubMed; PMID: 23152285.

5. Lazcano-Ponce E, Salazar-Martínez E, Gutiérrez-Castrellón P, et al. Ensayos clínicos aleatorizados: variantes, métodos de aleatorización, análisis, consideraciones éticas y regulación. Salud Pública de México [Internet]. 2004 [citado 12 May 2015];46(6):559- 84. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036- 36342004000600012&lng=es&nrm=iso&tlng=es

6. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials. Ann Intern Med. 2010; 152(11):726-32. Citado en PubMed; PMID: 20335313.

7. Barnhill A, Miller FG. The ethics of placebo treatments in clinical practice: a reply to Glackin. J Med Ethics. 2015; 41(8):673- 6. Citado en PubMed; PMID: 26100361.

8. Ćurković M1, Živković M, Radić K, et al. Ethical Overview of Placebo Control in Psychiatric Research - Concepts and Challenges. Psychiatr Danub. 2015;27(2):118- 25. Citado en PubMed; PMID:26057306.